| Is a Smartphone Application Effective as an Oral Medication Adherence Aid (NCT01968876) | University of Arkansas | 2013-10-30 |
| Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2 (NCT01970735) | Centre Hospitalier Universitaire de Nice | 2013-10-30 |
| Comprehensive Nano - Post Market Clinical Follow-Up Study (NCT03423953) | Zimmer Biomet | 2013-10-30 |
| Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer (NCT01910610) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2013-10-30 |
| Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device (NCT01624662) | Optinose US Inc. | 2013-10-30 |
| Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood (NCT02142569) | University of California, Los Angeles | 2013-10-30 |
| A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery (NCT01864746) | GBG Forschungs GmbH | 2013-10-30 |
| Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain (NCT01912612) | University of Michigan Rogel Cancer Center | 2013-10-30 |
| Biogen Multiple Sclerosis Pregnancy Exposure Registry (NCT01911767) | Biogen | 2013-10-30 |
| A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled (NCT02044419) | Aegerion Pharmaceuticals, Inc. | 2013-10-30 |
| SD-OCT Measurement of the Human Retina in Pregnancy With Pre-existing or De Novo Hypertension and Without Hypertension (NCT04286217) | University of Calgary | 2013-10-30 |
| Dual-task Training Using Virtual Reality (NCT03577353) | Loewenstein Hospital | 2013-10-30 |
| Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic) (NCT02267304) | Institut National de la Santé Et de la Recherche Médicale, France | 2013-10-30 |
| Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial (NCT03886779) | Silverstein Eye Centers | 2013-10-30 |
| A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects (NCT01984775) | Stiefel, a GSK Company | 2013-10-30 |
| Botswana Combination Prevention Project (NCT01965470) | Centers for Disease Control and Prevention | 2013-10-30 |
| A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults (NCT01987427) | Eisai Inc. | 2013-10-30 |
| A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) (NCT01891344) | pharmaand GmbH | 2013-10-30 |
| The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (NCT01975389) | Pfizer | 2013-10-29 |
| A Safety and Effectiveness Study of JUVÉDERM VOLIFT® XC Versus Control for Moderate to Severe Nasolabial Folds (NCT01976663) | Allergan | 2013-10-29 |
| KP-10 and Insulin Secretion in Men (NCT03771326) | Quaid-e-Azam University | 2013-10-29 |
| CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer (NCT01964378) | Tris Pharma, Inc. | 2013-10-29 |
| Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers (NCT01952444) | Elusys Therapeutics | 2013-10-29 |
| Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events (NCT01968967) | Pfizer | 2013-10-29 |
| Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer (NCT01787331) | University of California, San Francisco | 2013-10-29 |
| iCBT for Depression - Standard Versus Condensed Treatment Material (NCT01788657) | Örebro County Council | 2013-10-29 |
| The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (NCT01975376) | Pfizer | 2013-10-29 |
| Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults (NCT01988636) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-29 |
| A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events (NCT01959529) | Novo Nordisk A/S | 2013-10-29 |
| Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib (NCT01933945) | Bayer | 2013-10-28 |
| Targeted Small Airways Therapy in Persistent Asthma (NCT01894048) | University of Dundee | 2013-10-28 |
| A Study of PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/Lymphoma (NCT01973387) | Janssen Research & Development, LLC | 2013-10-28 |
| Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma (NCT01881789) | Amgen | 2013-10-28 |
| Physiopathologic Study of Induced by Thoracotomy / Thoracoscopy Neuropathy Mechanism (NCT05307471) | University Hospital, Clermont-Ferrand | 2013-10-28 |
| Registry on WATCHMAN Outcomes in Real-Life Utilization (NCT01972282) | Boston Scientific Corporation | 2013-10-28 |
| OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder (NCT01945489) | Allergan | 2013-10-28 |
| Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer Therapy (NCT01957514) | University of Washington | 2013-10-28 |
| Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI) (NCT01920243) | University of Michigan | 2013-10-28 |
| Combined Treatment for Mixed Incontinence (NCT01959347) | NICHD Pelvic Floor Disorders Network | 2013-10-28 |
| Evaluation of NT-proBNP in Chronic Inflammatory Bowel Disease (NCT03107390) | Centre Hospitalier Universitaire, Amiens | 2013-10-28 |
| Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT01912625) | National Cancer Institute (NCI) | 2013-10-28 |
| Blood Pressure Control for Type 2 Diabetes (NCT03477786) | National Health Research Institutes, Taiwan | 2013-10-28 |
| Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) (NCT01968668) | Bayer | 2013-10-28 |
| Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 (NCT01975818) | Bayer | 2013-10-28 |
| Functional Brain Imaging in Healthy Volunteers to Study Cognitive Functions (NCT01974427) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-10-26 |
| Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01866423) | University of Southern California | 2013-10-25 |
| Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy (NCT01980056) | Weill Medical College of Cornell University | 2013-10-25 |
| This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples (NCT01957189) | GlaxoSmithKline | 2013-10-25 |
| Study of Prognostic Factors in Aortic Dissection Type B (NCT01984905) | University Hospital, Caen | 2013-10-25 |
| A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer (NCT02000947) | MedImmune LLC | 2013-10-25 |
| Gender-specific Associations Between Quality of Life and Leukocyte Telomere Length (NCT03151824) | Jung-Ha Kim | 2013-10-25 |
| Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults (NCT01967940) | Gilead Sciences | 2013-10-25 |
| Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis (NCT01974804) | Memorial Sloan Kettering Cancer Center | 2013-10-25 |
| Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS). (NCT01835587) | Celgene | 2013-10-25 |
| F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma (NCT02054884) | Philogen S.p.A. | 2013-10-25 |
| Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis (NCT01960257) | University of California, San Diego | 2013-10-25 |
| T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer (NCT01967823) | National Cancer Institute (NCI) | 2013-10-24 |
| CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults (NCT03970304) | University of Maryland, Baltimore | 2013-10-24 |
| A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors (NCT01928394) | Bristol-Myers Squibb | 2013-10-24 |
| Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice (NCT01793142) | Pfizer | 2013-10-24 |
| Study of the Impact of the Regular Consumption of Polyphenol-rich Grape Juice on the Biological Parameters of Oxidative Stress and on Endothelial Function in Healthy Subjects (NCT02028936) | Centre Hospitalier Universitaire Dijon | 2013-10-24 |
| Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4) (NCT02428842) | Institut Curie | 2013-10-24 |
| Ultrasound Guided Posterior Sacroiliac Ligament Corticosteroid Injection in Pregnancy-Related Pelvic Girdle Pain (NCT02044991) | Loyola University | 2013-10-24 |
| Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma (NCT01849146) | National Cancer Institute (NCI) | 2013-10-24 |
| Preterm Infant Inhaled Albuterol Dosing (NCT02447250) | Oregon Health and Science University | 2013-10-24 |
| Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells (NCT03654794) | Rennes University Hospital | 2013-10-24 |
| Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD (NCT01958918) | Novartis Pharmaceuticals | 2013-10-23 |
| A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy (NCT01984008) | Universal Integrated Corp. | 2013-10-23 |
| Darapladib China PK (NCT02000804) | GlaxoSmithKline | 2013-10-23 |
| Robotic Assisted Surgery for Treatment of Gynecological Diseases: Pilot Study (NCT03093675) | SOFAR S.p.A. | 2013-10-23 |
| A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia (NCT01968980) | Pfizer | 2013-10-23 |
| Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer (NCT01896856) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-10-23 |
| Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women (NCT03528967) | Les Laboratoires des Médicaments Stériles | 2013-10-23 |
| Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension (NCT01915940) | ForSight Vision5, Inc. | 2013-10-23 |
| Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age (NCT01974895) | GlaxoSmithKline | 2013-10-23 |
| Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility (NCT02889341) | Vida Recoletas Sevilla | 2013-10-22 |
| Effects of Meditation on Cognitive Function and Quality of Life (NCT02162329) | M.D. Anderson Cancer Center | 2013-10-22 |
| Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients (NCT01995513) | Pfizer | 2013-10-22 |
| Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Patient Volunteers (NCT02790424) | University Hospital, Grenoble | 2013-10-22 |
| A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218) (NCT01866306) | Merck Sharp & Dohme LLC | 2013-10-22 |
| SMS Messaging to Reduce Depression and Anxiety Following TBI (NCT02061553) | Albert Einstein Healthcare Network | 2013-10-22 |
| Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known (NCT01971476) | Boehringer Ingelheim | 2013-10-22 |
| Ultrasound Confirmation of Endotracheal Tube Location Using a Saline Filled Cuff (NCT02131974) | The University of Texas Health Science Center, Houston | 2013-10-22 |
| FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents (NCT02055586) | Case Comprehensive Cancer Center | 2013-10-22 |
| A Safety Study of SGN-LIV1A in Breast Cancer Patients (NCT01969643) | Seagen Inc. | 2013-10-22 |
| Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer (NCT01872260) | Novartis Pharmaceuticals | 2013-10-22 |
| A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas (NCT01837862) | Julie Krystal | 2013-10-22 |
| Congenital Cytomegalovirus: Efficacy of Antiviral Treatment (NCT02005822) | Dr. Ann C.T.M. Vossen | 2013-10-22 |
| A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia (NCT01853228) | Janssen Research & Development, LLC | 2013-10-22 |
| Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) (NCT01852110) | Merck Sharp & Dohme LLC | 2013-10-22 |
| Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis (NCT01986920) | Aclaris Therapeutics, Inc. | 2013-10-22 |
| Bilateral Brain Stimulation in Trauma Therapy (NCT03086083) | Ciclo de Mutação | 2013-10-21 |
| A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma (NCT01837316) | GlaxoSmithKline | 2013-10-21 |
| Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum (NCT03909178) | Massachusetts General Hospital | 2013-10-21 |
| User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application (NCT03748264) | Philips Respironics | 2013-10-21 |
| Zimmer POLAR - Total Knee Arthroplasty (TKA) (NCT01859130) | Zimmer Biomet | 2013-10-21 |
| A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of Outcomes (NCT01979159) | VA Office of Research and Development | 2013-10-21 |
| Self Regulated Physical Activity and Bone Growth Enhancement in Premature Infants (NCT03884322) | Asante Health System | 2013-10-21 |
| Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast Cancer (NCT02056886) | Institut Cancerologie de l'Ouest | 2013-10-21 |
| Olaparib and Radiotherapy in Inoperable Breast Cancer (NCT02227082) | The Netherlands Cancer Institute | 2013-10-21 |